首页> 外文OA文献 >Safety of the primary percutaneous coronary intervention strategy combining pre-hospital prasugrel, enoxaparin and in-hospital bivalirudin in acute ST-segment elevation myocardial infarction

【2h】

Safety of the primary percutaneous coronary intervention strategy combining pre-hospital prasugrel, enoxaparin and in-hospital bivalirudin in acute ST-segment elevation myocardial infarction

机译：院前普拉格雷，依诺肝素和院内比伐卢定联合经皮冠状动脉介入治疗在急性ST段抬高型心肌梗死中的安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Juho Viikilä; Tuomo Nieminen; Ilkka Tierala; Mika Laine;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety of the primary percutaneous coronary intervention strategy combining pre-hospital prasugrel, enoxaparin and in-hospital bivalirudin in acute ST-segment elevation myocardial infarction [J] . Juho Viikil?, Tuomo Nieminen, Ilkka Tierala, BMC Cardiovascular Disorders . 2016,第1期

机译：院前普拉格雷，依诺肝素和院内比伐卢定联合经皮冠状动脉介入治疗在急性ST段抬高型心肌梗死中的安全性
2. Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Insights from the ORBI registry [J] . Auffret Vincent, Leurent Guillaume, Boulmier Dominique, Archives of cardiovascular diseases . 2016,第12期

机译：院前给予普通肝素，依诺肝素或比伐卢定的院前给药对ST段抬高型心肌梗死行经皮冠状动脉介入治疗的患者的疗效和安全性：ORBI注册资料
3. Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction Registry [J] . Song Fei, Yu Mengyue, Yang Jingang, The American Journal of Cardiology . 2016,第9期

机译：中国原发性经皮冠状动脉介入治疗ST段抬高型心肌梗死患者的症状发作至气球时间，ST段消退和住院死亡率：来自中国急性心肌梗死登记处
4. Impact of Renal Insufficiency on 30-Day Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention [C] . Sakai K., Tosaka A., Soga Y., World Congress on Heart Disease. . 2013

机译：肾功能不全对初级经皮冠状动脉干预治疗的ST段升高心肌梗死患者30天后的影响
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Safety of the primary percutaneous coronary intervention strategy combining pre-hospital prasugrel enoxaparin and in-hospital bivalirudin in acute ST-segment elevation myocardial infarction [O] . Juho Viikilä, Tuomo Nieminen, Ilkka Tierala, 2016

机译：院前普拉格雷依诺肝素和院内比伐卢定联合经皮冠状动脉介入治疗在急性ST段抬高型心肌梗死中的安全性
7. Safety of the primary percutaneous coronary intervention strategy combining pre-hospital prasugrel, enoxaparin and in-hospital bivalirudin in acute ST-segment elevation myocardial infarction [O] . Viikila, Juho, Nieminen, Tuomo, Tierala, Ilkka, 2016

机译：院前普拉格雷，依诺肝素和院内比伐卢定联合经皮冠状动脉介入治疗在急性ST段抬高型心肌梗死中的安全性

Safety of the primary percutaneous coronary intervention strategy combining pre-hospital prasugrel, enoxaparin and in-hospital bivalirudin in acute ST-segment elevation myocardial infarction

著录项

引文网络

相似文献

相关主题

期刊订阅